Alicia Duval

Alicia Duval

Auto-generated profile, based on publicly available information

Alicia Duval

Department of Psychology, McGill University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2022 in Cancer
Verified
Journal Article
Closed access
ADAlicia Duval
Alicia Duval
CDChristopher G. Davis
Christopher G. Davis
EKEve‐Ling Khoo
Eve‐Ling Khoo
HRHeather Romanow
Heather Romanow
YSYaadwinder Shergill
Yaadwinder Shergill
BCBarbara Collins
Barbara Collins

29 August 2023 in Experimental Physiology
Verified
Journal Article
Open access
ADAlicia Duval
Alicia Duval
WHWill Huckins
Will Huckins
DBDanielle E. Berbrier
Danielle E. Berbrier
CUCharlotte W. Usselman
Charlotte W. Usselman
Polycystic ovary syndrome (PCOS) is a complex disorder characterized by reproductive abnormalities, cardiometabolic disturbances and a heightened risk of cardiovascular disease. A small but compelling body of research demonstrates that females with PCOS present with elevated muscle sympathetic nerve activity (MSNA) at rest. Heightened MSNA is present in lean, overweight and obese females with PCOS, but limited evidence suggests that androgens may be more strongly linked to elevated MSNA in lean females with PCOS than in obese females with PCOS. Although the specific mechanisms underlying elevated MSNA in PCOS remain elusive, sympathetic activation is implicated in the progression of several cardiovascular diseases and may contribute to the cardiovascular pathophysiology of PCOS. Encouragingly, MSNA appears responsive to non‐pharmacological intervention, making the sympathetic nervous system a promising therapeutic target to mitigate cardiovascular risk in PCOS. This brief review summarizes the existing evidence regarding elevated MSNA, cardiovascular risk profile and vascular function, as well as the potential for clinical intervention and future research directions in females with PCOS.

1 June 2024 in Journal of Experimental Psychology: General
Verified
Journal Article
Closed access
ADAlicia Duval
Alicia Duval
ABAnne Beatty-Martínez
Anne Beatty-Martínez
SPStamatoula Pasvanis
Stamatoula Pasvanis
ACArielle Crestol
Arielle Crestol
JSJamie Snytte
Jamie Snytte
DTDebra Titone
Debra Titone
Menopause is associated with declines in cognitive control. However, there is individual variability in the slope of this decline. Recent work suggests that indices of cognitive control are mediated by communicative demands of the language environment. However, little is known about how the impact of bilingual experience generalizes across the lifespan, particularly in females who exhibit steeper cognitive decline due to increasing age and menopausal transition. Thus, we investigated whether diversity of language use in distinct communicative contexts modulated the effects of aging and menopause on cognitive control in an adult lifespan sample of healthy females. We performed robust linear regressions on a sample of 120 females (age range 20-65 years) to characterize age- (n = 120) and menopause-related (n = 59) declines in cognitive control (as assessed by the Wisconsin Card Sorting Test) and to determine whether they are modulated by different facets of bilingual language experience, including the diversity of language use (i.e., language entropy) in home and workplace environments. Workplace but not home language diversity modulated age- and menopause-related declines in cognitive control, suggesting that females may compensate for decline by virtue of adapting to the externally imposed demands of the language environment. These findings have implications for identifying which aspects of bilingual experience may contribute to cognitive reserve in healthy aging. (PsycInfo Database Record (c) 2024 APA, all rights reserved).

7 October 2026 in Journal of Health Psychology
Verified
Journal Article
Open access
ADAlicia Duval
Alicia Duval
DBDanielle E. Berbrier
Danielle E. Berbrier
ACArielle Crestol
Arielle Crestol
BSBrittany K. Schwende
Brittany K. Schwende
BDBlaine Ditto
Blaine Ditto
CUCharlotte W. Usselman
Charlotte W. Usselman
This review synthesized the effects of mindfulness-based (MBIs) and cognitive behavior-based (CBIs) interventions on psychological and physiological outcomes in females with polycystic ovary syndrome (PCOS). Searches across PsycINFO, MEDLINE, Scopus, and ProQuest identified randomized and non-randomized controlled trials. Twelve studies ( n = 5 MBIs; n = 7 CBIs) published between 2015 and 2024 met criteria. Mean sample sizes were 54 (MBIs; n = 269; range = 45–66) and 94 (CBIs; n = 374; range = 33–183). Both intervention types improved psychological outcomes. MBIs showed benefits for depression, anxiety, stress, self-esteem, and body image, whereas CBIs improved depression, anxiety, self-esteem, and PCOS-related quality of life. Physiological findings were inconsistent. CBIs showed potential reductions in weight, systolic blood pressure, free androgen index, and anti-mullerian hormone, while MBIs reduced free testosterone and cortisol. Overall, CBIs and MBIs show promise for improving psychological well-being, whereas physiological benefits remain inconclusive. More robust trials are needed to clarify the long-term benefits.